Skip to content
Screener

Penumbra PEN Q1 2025 earnings

Reported April 23, 2025 · After market close

Revenue$324.1MMiss by $3.1M
EPS$0.83Beat by $0.17
Revenue estimate$327.3M
EPS estimate$0.66

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$401.4M
EPS estimate$1.20

Financials

Q1 2025

Income statement

See full
Revenue$324.1M+16.3%
Gross profit$215.9M+19.2%
Operating income$40.4M+233%
Net income$39.2M+257%
EPS (diluted)$1.00+257%

Balance sheet

See full
Cash & equivalents$376.1M+68.5%
Total debt$220.7M-4.7%
Total equity$1.2B+0.8%
Total assets$1.6B+0.9%

Cash flow

See full
Operating cash flow$49.0M+27.9%
CapEx$13.5M+131%
Free cash flow$35.5M+9.3%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$10.3B+19.2%
Enterprise value$10.14B+17.3%
P/E243.9×+151×
P/S8.3×+0.4×

Profitability

See full
Gross margin63.7%-1.4pp
Operating margin3%-4.1pp
Net margin3.4%-5.1pp
FCF margin12.1%+2.5pp

Returns & leverage

See full
Return on equity3.5%-4.9pp
Debt / equity0.2×0.0×
Current ratio6.3×+0.2×

Segments

By product

See full
Thrombectomy$226.5M+20.7%
Embolization and Access$97.6M+7.3%

FAQ

When did Penumbra report Q1 2025 earnings?
Penumbra (PEN) reported Q1 2025 earnings on April 23, 2025 after market close.
What were Penumbra's Q1 2025 revenue and EPS?
Penumbra reported revenue of $324.1M and eps of $0.83 for Q1 2025.
Did Penumbra beat estimates in Q1 2025?
Revenue missed the consensus estimate of $327.3M by $3.1M. EPS beat the consensus estimate of $0.66 by $0.17.
How did Penumbra's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.3% from $278.7M a year earlier and eps grew 102.4% from $0.41.
Where can I find Penumbra's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001321732-25-000085) and the 10-Q periodic report (0001321732-25-000086) directly on SEC EDGAR. The filing index links above go to sec.gov.